Site 0231 - Northwell Health Cancer Institute is a clinical research site located in Manhasset, New York, United States 11030.
Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.
Site 0231 - Northwell Health Cancer Institute has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
Sponsors: K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in New York · View every site in Manhasset
Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Site 0231 - Northwell Health Cancer Institute has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Site 0231 - Northwell Health Cancer Institute has 1 clinical trials on record, with 1 currently active. Their work covers High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
Site 0231 - Northwell Health Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.